Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement: A Report of Two Cases

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Kiyotaka Uchiyama , Masako Otani , Naoki Chigusa , Kazuya Sugita , Ryosuke Matsuoka , Koji Hosoya , Mina Komuta , Jun Ito , Naoki Washida
{"title":"Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement: A Report of Two Cases","authors":"Kiyotaka Uchiyama ,&nbsp;Masako Otani ,&nbsp;Naoki Chigusa ,&nbsp;Kazuya Sugita ,&nbsp;Ryosuke Matsuoka ,&nbsp;Koji Hosoya ,&nbsp;Mina Komuta ,&nbsp;Jun Ito ,&nbsp;Naoki Washida","doi":"10.1016/j.xkme.2024.100908","DOIUrl":null,"url":null,"abstract":"<div><div>Numerous health concerns, primarily kidney injury, have been reported with the use of Beni-kōji CholesteHelp, a functional food containing red yeast rice. Here, we describe 2 cases of kidney injury caused by beni-kōji. The first case had normal kidney function before consuming the product. After several months of use, she developed hypertension. After 6 months of supplement consumption, her estimated glomerular filtration rate (eGFR) dropped to 22.5<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>. A spot urine sample showed a urinary protein-to-creatinine ratio of 2.03<!--> <!-->g/g, leading to the diagnosis of Fanconi syndrome. Kidney biopsy showed tubular degeneration. Thirty-five days after discontinuing the supplement, proteinuria resolved and the eGFR returned to baseline level. The second case, who had diabetes and normal kidney function, experienced severe kidney injury (eGFR, 3.5<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>) after 4 months of Beni-kōji CholesteHelp use. He required hemodialysis for<!--> <!-->&gt;2 weeks but recovered kidney function after the product was discontinued. Kidney biopsy showed tubular injury similar to the first case and glomeruli changes consistent with diabetic nephropathy. These cases indicate that beni-kōji use is associated with tubular toxicity. Further studies are required to identify the precise etiology and mechanism of kidney injury.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524001195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Numerous health concerns, primarily kidney injury, have been reported with the use of Beni-kōji CholesteHelp, a functional food containing red yeast rice. Here, we describe 2 cases of kidney injury caused by beni-kōji. The first case had normal kidney function before consuming the product. After several months of use, she developed hypertension. After 6 months of supplement consumption, her estimated glomerular filtration rate (eGFR) dropped to 22.5 mL/min/1.73 m2. A spot urine sample showed a urinary protein-to-creatinine ratio of 2.03 g/g, leading to the diagnosis of Fanconi syndrome. Kidney biopsy showed tubular degeneration. Thirty-five days after discontinuing the supplement, proteinuria resolved and the eGFR returned to baseline level. The second case, who had diabetes and normal kidney function, experienced severe kidney injury (eGFR, 3.5 mL/min/1.73 m2) after 4 months of Beni-kōji CholesteHelp use. He required hemodialysis for >2 weeks but recovered kidney function after the product was discontinued. Kidney biopsy showed tubular injury similar to the first case and glomeruli changes consistent with diabetic nephropathy. These cases indicate that beni-kōji use is associated with tubular toxicity. Further studies are required to identify the precise etiology and mechanism of kidney injury.
与红麴(Beni-kōji)补充剂有关的急性肾损伤:两个病例的报告
使用含有红麴的功能性食品 Beni-kōji CholesteHelp 引起了许多健康问题,主要是肾损伤。在此,我们描述了两例由 Beni-kōji 引起的肾损伤。第一个病例在服用该产品前肾功能正常。服用几个月后,她患上了高血压。服用补充剂 6 个月后,她的肾小球滤过率(eGFR)降至 22.5 mL/min/1.73 m2。点滴尿样显示尿蛋白与肌酐的比率为 2.03 g/g,因此被诊断为范科尼综合征。肾活检显示肾小管退化。停用补充剂 35 天后,蛋白尿消失,eGFR 恢复到基线水平。第二个病例患有糖尿病,肾功能正常,在服用贝尼可司胆石通 4 个月后,出现了严重的肾损伤(eGFR,3.5 mL/min/1.73 m2)。他需要进行 2 周的血液透析,但停药后肾功能恢复。肾活检显示肾小管损伤与第一个病例相似,肾小球变化与糖尿病肾病一致。这些病例表明,使用苯光吉与肾小管毒性有关。要确定肾损伤的确切病因和机制,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信